
.jpg)
Novartis UK Webinar
Introducing inclisiran▼ in your region:
How to take a Population Health Management approach to lipid management
This promotional meeting is organised and funded by Novartis Pharmaceuticals UK Ltd.
UK | February 2022 | 189786
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.UK/yellowcard.
Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com.
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com
To learn about your data privacy rights and the use of your personal information, we invite you to read our General Privacy Notice for Business Partners.